Formation of N -Nitrosamine Drug Substance Related Impurities in Medicines: A Regulatory Perspective on Risk Factors and Mitigation Strategies
Organic Process Research & Development · 20.10.2023 · 27 (10) · 1736-1750
DOI: 10.1021/acs.oprd.3c00153 ↗Kurz gefasst
Fachartikel in der Zeitschrift Organic Process Research & Development, online erschienen am 21.07.2023. Verfasst von Răzvan C. Cioc und 3 weiteren Autor:innen. Die Arbeit wurde bisher 149-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Cioc, R. C., Joyce, C., Mayr, M., & Bream, R. N. (2023). Formation of N -Nitrosamine Drug Substance Related Impurities in Medicines: A Regulatory Perspective on Risk Factors and Mitigation Strategies. Organic Process Research & Development, 27(10), 1736-1750. https://doi.org/10.1021/acs.oprd.3c00153
Vancouver
Cioc RC, Joyce C, Mayr M, Bream RN. Formation of N -Nitrosamine Drug Substance Related Impurities in Medicines: A Regulatory Perspective on Risk Factors and Mitigation Strategies. Organic Process Research & Development. 2023;27(10):1736-1750. doi:10.1021/acs.oprd.3c00153
BibTeX
@article{Cioc2023,
author = {Cioc, Răzvan C. and Joyce, Ciarán and Mayr, Monika and Bream, Robert N.},
title = {Formation of N -Nitrosamine Drug Substance Related Impurities in Medicines: A Regulatory Perspective on Risk Factors and Mitigation Strategies},
journal = {Organic Process Research & Development},
year = {2023},
volume = {27},
number = {10},
pages = {1736--1750},
doi = {10.1021/acs.oprd.3c00153}
}
EUVIMED